Forum Scope


Match



Forum Options



Min search length: 3 characters / Max search length: 84 characters
Forum Login
Lost password?
sp_TopicIcon
Corbus Pharmaceuticals Holdings, Inc. Stats
Avatar
Meredith_Editor
84 Posts
(Offline)
1
March 18, 2021 - 10:39 am
Print


Corbus Pharmaceuticals Holdings
Corbus Pharmaceuticals Holdings, Inc., a clinical-stage pharmaceutical company, focuses on the development and commercialization of novel therapeutics that target the endocannabinoid system in the fields of autoimmunity, fibrosis, and cancer. Its lead product candidate is lenabasum, a cannabinoid receptor type 2 (CB2) that is in Phase III clinical trial for the treatment of dermatomyositis; and in Phase II clinical trial to treat systemic lupus erythematosus. The company is also developing cannabinoid receptor type 1 inverse agonist program for treatment of metabolic disorders, such as obesity, diabetic nephropathy, diabetic retinopathy, and nonalcoholic steatohepatitis; and CB2 agonist program for the treatment of cancer. It has a licensing agreement with Jenrin Discovery, LLC to develop and commercialize the licensed products, which includes the Jenrin library of approximately 600 compounds and multiple issued and pending patent filings; and strategic collaboration with Kaken Pharmaceutical Co., Ltd. for the development and commercialization of lenabasum in Japan. The company was incorporated in 2009 and is based in Norwood, Massachusetts.
Healthcare
Biotechnology
617 963 0100
http://www.corbuspharma.com

Corbus Pharmaceuticals HoldingsCRBP
9.73%
$1.02

Forum Timezone: America/New_York
All RSSShow Stats
Administrators: admin
Top Posters:
Meredith_Editor: 84
Mike Smith: 1
Newest Members:
dogecoinwap352 dogecoinwap352
Alexovm Alexovm
Ivanmwt Ivanmwt
Meredith_Editor
Daniel Decamp
Daniel DeCamp
Mike Smith
Daniel Decamp
Forum Stats:
Groups: 1
Forums: 85
Topics: 85
Posts: 85

 

Member Stats:
Guest Posters: 0
Members: 8
Moderators: 0
Admins: 1

Most Users Ever Online
10
Currently Online
Guest(s)
2
Currently Browsing this Page

1 Guest(s)